Trop2 is a transmembrane glycoprotein that is overexpressed in a variety of solid cancers such as breast cancer, lung cancer, and urothelial carcinoma with minimal or no baseline expression in normal tissues. Here, TACSTD2 is linked to urothelial carcinoma.